Last reviewed · How we verify
NCT05545332: PRECISE
Prospective Multidisciplinary Post-COVID-19 Registry Tyrol
trial in Post COVID-19 Condition in 600 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Medical University Innsbruck |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 3 March 2022 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Austria |
Conditions studied
- Post COVID-19 Condition — all drugs for Post COVID-19 Condition →
Sponsor
Medical University Innsbruck
Who can join
Eligibility, any sex, with Post COVID-19 Condition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Longitudinal, prospective observational cohort study enrolling patients with persisting symptoms (\> 12 weeks) after COVID-19 in a multidisciplinary care model.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
[Occupational Therapy Guideline for the management of sequelae of viral diseases with SARS-CoV-2 : Supplement to the S1 guidelines for the management of post-viral conditions exemplified by post-COVID-19].
Costa UM. · · 2023 · cited 5× · PMID 37522912 · DOI 10.1007/s00508-023-02243-y
Verify or expand the search:
- PubMed search for NCT05545332
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post COVID-19 Condition
Currently open trials in the same condition.
- NCT07110714 — Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients · NA · recruiting
- NCT06156176 — Pursuing Reduction in Fatigue After COVID-19 Via Exercise and Rehabilitation (PREFACER): A Randomized Feasibility Trial · NA · recruiting
- NCT06766825 — Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC) · Phase 2 · recruiting
- NCT05946512 — MR-spectroscopy in Post-covid Condition Prior to and Following a Yoga Breathing Intervention · NA · recruiting
- NCT05890534 — Pycnogenol® in Post-COVID-19 Condition · Phase 3 · active not recruiting
Other Medical University Innsbruck trials
Trials by the same sponsor.
- NCT07408726 — Monoaxial vs. Polyaxial Percutaneous Hybrid Stabilization · NA · not yet recruiting
- NCT07101107 — Socio-cognitive and Biological Responses to Maltreatment · not yet recruiting
- NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
- NCT07434648 — Comparison of Mastectomy Expander Trial · NA · not yet recruiting
- NCT07391683 — Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05545332 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University Innsbruck
- Last refreshed: 19 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05545332.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing